Meeder Asset Management’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
– Sell
-17
Closed – – 1877
2022
Q3
$0 Sell
17
-16
-48% -$561 ﹤0.01% 2365
2022
Q2
$1K Buy
33
+8
+32% +$340 ﹤0.01% 2079
2022
Q1
$2K Sell
25
-50
-67% -$3.6K ﹤0.01% 2084
2021
Q4
$7K Buy
75
+7
+10% +$837 ﹤0.01% 826
2021
Q3
$9K Buy
68
+34
+100% +$4.95K ﹤0.01% 1721
2021
Q2
$6K Sell
34
-8
-19% -$1.3K ﹤0.01% 1900
2021
Q1
$7K Sell
42
-47
-53% -$10.9K ﹤0.01% 1748
2020
Q4
$18K Sell
89
-2,531
-97% -$515K ﹤0.01% 832
2020
Q3
$575K Sell
2,620
-744
-22% -$158K 0.04% 330
2020
Q2
$642K Buy
3,364
+1,119
+50% +$196K 0.04% 318
2020
Q1
$349K Buy
+2,245
New +$261K 0.03% 425
2017
Q2
– Sell
-273
Closed -$7K – 1866
2017
Q1
$7K Sell
273
-583
-68% -$12.1K ﹤0.01% 963
2016
Q4
$14K Buy
+856
New +$14.5K ﹤0.01% 698

Other funds holding TDOC

Meeder Asset Management's TDOC Position: Q4 2022 in Review

Meeder Asset Management sold out of Teladoc Health (TDOC) in Q4 2022, closing a stake of 17 shares.

Meeder Asset Management first reported a position in TDOC in Q4 2016 and held it in 13 quarters. The position peaked at $642K in Q2 2020. 443 funds tracked by Wall St. Rank hold TDOC as of Q4 2022.

  • Meeder Asset Management reported no remaining Teladoc Health position as of Q4 2022 after selling out during the quarter.
  • Meeder Asset Management sold 17 Teladoc Health shares in Q4 2022.
  • Meeder Asset Management first reported a position in Teladoc Health in Q4 2016 and held it in 13 quarters.
  • Meeder Asset Management's Teladoc Health position peaked at $642K in Q2 2020.
  • 443 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2022.

Based on Meeder Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.